429 related articles for article (PubMed ID: 29342201)
21. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
[TBL] [Abstract][Full Text] [Related]
22. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.
Wang S; Kim S; Chawla S; Wolf RL; Knipp DE; Vossough A; O'Rourke DM; Judy KD; Poptani H; Melhem ER
AJNR Am J Neuroradiol; 2011 Mar; 32(3):507-14. PubMed ID: 21330399
[TBL] [Abstract][Full Text] [Related]
23. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
[TBL] [Abstract][Full Text] [Related]
24. Differentiation of Glioblastoma and Solitary Brain Metastasis by Gradient of Relative Cerebral Blood Volume in the Peritumoral Brain Zone Derived from Dynamic Susceptibility Contrast Perfusion Magnetic Resonance Imaging.
She D; Xing Z; Cao D
J Comput Assist Tomogr; 2019; 43(1):13-17. PubMed ID: 30015801
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric MRI for Differentiation of Radiation Necrosis From Recurrent Tumor in Patients With Treated Glioblastoma.
Nael K; Bauer AH; Hormigo A; Lemole M; Germano IM; Puig J; Stea B
AJR Am J Roentgenol; 2018 Jan; 210(1):18-23. PubMed ID: 28952810
[TBL] [Abstract][Full Text] [Related]
26. Differentiating Primary Central Nervous System Lymphomas From Glioblastomas and Inflammatory Demyelinating Pseudotumor Using Relative Minimum Apparent Diffusion Coefficients.
Wen JB; Huang WY; Xu WX; Wu G; Geng DY; Yin B
J Comput Assist Tomogr; 2017; 41(6):904-909. PubMed ID: 28708728
[TBL] [Abstract][Full Text] [Related]
27. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
[TBL] [Abstract][Full Text] [Related]
28. Utility of Percentage Signal Recovery and Baseline Signal in DSC-MRI Optimized for Relative CBV Measurement for Differentiating Glioblastoma, Lymphoma, Metastasis, and Meningioma.
Lee MD; Baird GL; Bell LC; Quarles CC; Boxerman JL
AJNR Am J Neuroradiol; 2019 Sep; 40(9):1445-1450. PubMed ID: 31371360
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of enhancement-perfusion mismatch in differentiation of CNS lymphomas from other enhancing malignant tumors of the brain.
Goyal P; Kumar Y; Gupta N; Malhotra A; Gupta S; Gupta S; Mangla M; Mangla R
Quant Imaging Med Surg; 2017 Oct; 7(5):511-519. PubMed ID: 29184763
[TBL] [Abstract][Full Text] [Related]
30. New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.
Blasel S; Vorwerk R; Kiyose M; Mittelbronn M; Brunnberg U; Ackermann H; Voss M; Harter PN; Hattingen E
J Neurol; 2018 Mar; 265(3):647-658. PubMed ID: 29383512
[TBL] [Abstract][Full Text] [Related]
31. Single brain metastasis versus glioblastoma multiforme: a VOI-based multiparametric analysis for differential diagnosis.
Romano A; Moltoni G; Guarnera A; Pasquini L; Di Napoli A; Napolitano A; Espagnet MCR; Bozzao A
Radiol Med; 2022 May; 127(5):490-497. PubMed ID: 35316518
[TBL] [Abstract][Full Text] [Related]
32. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of glioblastoma and primary central nervous system lymphomas using multiparametric diffusion and perfusion magnetic resonance imaging.
Hung ND; Anh NN; Minh ND; Huyen DK; Duc NM
Biomed Rep; 2023 Nov; 19(5):82. PubMed ID: 37881606
[TBL] [Abstract][Full Text] [Related]
34. Dynamic susceptibility contrast (DSC) perfusion MRI in differential diagnosis between radionecrosis and neoangiogenesis in cerebral metastases using rCBV, rCBF and K2.
Muto M; Frauenfelder G; Senese R; Zeccolini F; Schena E; Giurazza F; Jäger HR
Radiol Med; 2018 Jul; 123(7):545-552. PubMed ID: 29508242
[TBL] [Abstract][Full Text] [Related]
35. Validation of combined use of DWI and percentage signal recovery-optimized protocol of DSC-MRI in differentiation of high-grade glioma, metastasis, and lymphoma.
Cindil E; Sendur HN; Cerit MN; Dag N; Erdogan N; Celebi FE; Oner Y; Tali T
Neuroradiology; 2021 Mar; 63(3):331-342. PubMed ID: 32821962
[TBL] [Abstract][Full Text] [Related]
36. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
37. Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.
Yu H; Lou H; Zou T; Wang X; Jiang S; Huang Z; Du Y; Jiang C; Ma L; Zhu J; He W; Rui Q; Zhou J; Wen Z
Eur Radiol; 2017 Nov; 27(11):4516-4524. PubMed ID: 28534162
[TBL] [Abstract][Full Text] [Related]
38. Histogram analysis of apparent diffusion coefficient maps for differentiating primary CNS lymphomas from tumefactive demyelinating lesions.
Lu SS; Kim SJ; Kim N; Kim HS; Choi CG; Lim YM
AJR Am J Roentgenol; 2015 Apr; 204(4):827-34. PubMed ID: 25794073
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of primary central nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging.
Xing Z; You RX; Li J; Liu Y; Cao DR
Clin Neuroradiol; 2014 Dec; 24(4):329-36. PubMed ID: 23994941
[TBL] [Abstract][Full Text] [Related]
40. Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.
Askaner K; Rydelius A; Engelholm S; Knutsson L; Lätt J; Abul-Kasim K; Sundgren PC
J Neuroradiol; 2019 Nov; 46(6):367-372. PubMed ID: 30389510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
